3M (MMM) continues to navigate a tumultuous landscape marked by significant volatility and recent structural changes, including the spin-off of its healthcare division, Solventum. While the stock has surged nearly 70% over the past three years, it remains down 11% over the last five years and is currently 15% off its 52-week high. Investors may find the stock appealing due to its diversified portfolio and a 2.1% dividend yield, which has seen two increases since its reduction in 2024.
However, 3M’s ongoing legal challenges related to military earplugs and forever chemicals cast a shadow over its recovery. The lack of transparency regarding these legal issues creates uncertainty, making it a potential red flag for risk-averse investors. The adjusted earnings for 2025 indicate a positive trajectory, but the removal of litigation-related expenses highlights the impact of these challenges on profitability.
For those holding 3M, the key takeaway is to brace for continued volatility as the company works through its legal troubles while striving for growth. Investors should weigh their tolerance for risk against the potential for long-term recovery.
Source: fool.com